» Articles » PMID: 8503855

Synthesis of Oligopeptide Chloromethanes to Investigate Extended Binding Regions of Proteinases: Application to the Interaction of Fibrinogen with Thrombin

Overview
Journal Biochem J
Specialty Biochemistry
Date 1993 May 15
PMID 8503855
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A method was established for the synthesis of oligopeptide chloromethanes which should be useful in the study of serine and cysteine proteinases with extended binding sites. The method involved condensation of an N-terminal peptide fragment obtained by solid-phase synthesis with a C-terminal peptide chloromethane synthesized by solution-phase chemistry. By using this procedure, oligopeptide chloromethanes of up to 16 residues were synthesized. These chloromethanes were based on the sequence of fibrinopeptide A. By using oligopeptide chloromethanes of different length, it was possible to show that the residues Asp7-Phe8-Leu9 play a crucial role in the recognition of fibrinopeptide A by thrombin. In contrast, the residues Ala1-Asp2-Ser3-Gly4-Glu5-Gly6 seem to play a minor role. Substitution of valine for Gly12, which occurs in a dysfibrinogenaemia, markedly decreased the rate of inactivation of thrombin by the oligopeptide chloromethane. The results are discussed in terms of the recently published structure of the complex between human thrombin and a chloromethane inhibitor based on fibrinopeptide A.

Citing Articles

Thrombin: An Approach to Developing a Higher-Order Reference Material and Reference Measurement Procedure for Substance Identity, Amount, and Biological Activities.

Jackson C, Esnouf P, Duewer D J Res Natl Inst Stand Technol. 2024; 125:125021.

PMID: 39035347 PMC: 10871826. DOI: 10.6028/jres.125.021.


Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.

Bontemps Y, Scamuffa N, Calvo F, Khatib A Med Res Rev. 2006; 27(5):631-48.

PMID: 17019676 PMC: 7168524. DOI: 10.1002/med.20072.


Endo/exo-proteolysis in neoplastic progression and metastasis.

Khatib A, Bassi D, Siegfried G, Klein-Szanto A, Ouafik L J Mol Med (Berl). 2005; 83(11):856-64.

PMID: 16133424 DOI: 10.1007/s00109-005-0692-y.


Allosteric modulation of the activity of thrombin.

Duffy E, Angliker H, Le Bonniec B, Stone S Biochem J. 1997; 321 ( Pt 2):361-5.

PMID: 9020867 PMC: 1218077. DOI: 10.1042/bj3210361.

References
1.
Stone S, Betz A, Hofsteenge J . Mechanistic studies on thrombin catalysis. Biochemistry. 1991; 30(41):9841-8. DOI: 10.1021/bi00105a005. View

2.
Martin P, Robertson W, Turk D, Huber R, Bode W, EDWARDS B . The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. J Biol Chem. 1992; 267(11):7911-20. View

3.
Stubbs M, Oschkinat H, Mayr I, Huber R, Angliker H, Stone S . The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992; 206(1):187-95. DOI: 10.1111/j.1432-1033.1992.tb16916.x. View

4.
Hogg D, Blomback B . The specificity of the fibrinogen-thrombin reaction. Thromb Res. 1974; 5(5):685-93. DOI: 10.1016/0049-3848(74)90057-7. View

5.
Hageman T, Scheraga H . Mechanism of action of thrombin on fibrinogen. Reaction of the N-terminal CNBr fragment from the Aalpha chain of human fibrinogen with bovine thrombin. Arch Biochem Biophys. 1974; 164(2):707-15. DOI: 10.1016/0003-9861(74)90083-6. View